Clinical Supply Manufacturing Recources
-
Vial Containment Systems For Gene And Cell Therapies
5/24/2024
CZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.
-
De-Risking Your Bioconjugate's Path To Clinical Manufacturing
9/30/2022
Explore the challenges when moving a bioconjugate candidate from early development to clinic, along with integrated solutions for navigating this growing area of the biopharmaceutical industry.
-
Breaking Down Early Small Molecule Development
3/11/2026
Adopt an integrated development strategy to streamline the path from early development to the clinic, ensuring timely clinical supply while reducing delays, risk, and inefficiencies.
-
Sponsor Overcomes Hold And Steers Products Through Development
11/2/2023
Uncover how a small-sized biotech company was able to resolve critical regulatory CMC deficiencies to meet FDA requirements.
-
Overcoming Challenges In Cell And Gene Therapy Containment
Review the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.
-
Solving Logistic Complexities In The Era Of Personalized Medicine
1/1/2022
Examine how the next generation of therapies is disrupting supply chain logistics and explore solutions for the complexities within cell and gene therapies.
-
Expertise And Transparency Drive A Distinct Development Journey
1/26/2026
Coordinated expertise, real‑time visibility, and clear communication support smoother development, manufacturing, and clinical supply. Strong alignment improves predictability and lowers risk.
-
Optimizing Cell Therapy Supply Chains For Success
When it comes to transporting highly sensitive and valuable materials, such as cell therapies, learn how teams can ensure that unique storage and distribution requirements are met.
-
A Practical Packaging Components Checklist For Emerging Biotechs
6/20/2024
A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.
-
Specializing In Small And Early-Stage Partners, Not Just Small Batches
8/16/2023
Many small and/or early-stage companies are not aware of the need, or the possibility, of finding a CDMO that specializes in meeting their specific requirements.